A STUDY ON CLINICAL PROFILE AND COMPLICATIONS IN CHILDREN BELOW 14 YEARS OF AGE WITH TYPE 1 DIABETES MELLITUS ADMITTED IN A TERTIARY CARE HOSPITAL IN SOUTH INDIA: A CROSS-SECTIONAL STUDY
DOI:
https://doi.org/10.22159/ajpcr.2025v18i8.55131Keywords:
Type 1 diabetes mellitus, Diabetic ketoacidosis, Hyperglycemia, Insulin.Abstract
Objective: Type 1 diabetes mellitus (DM) is a common disease in children presenting with acute complications such as diabetic ketoacidosis (DKA). This study was undertaken to study the clinical profile, biochemical parameters, acute complications, associated comorbidities, and outcomes in children admitted with Type 1 DM in a tertiary care hospital.
Methods: This is a hospital-based cross-sectional study conducted in a tertiary hospital.
Results: A total of 38 children were included in the study. Most of the children were between 5 and 10 years (47.37%) with a slightly high female preponderance (60.53%). The mean age at diagnosis was 7.25 years, and 63.16% of children were newly diagnosed. Most of the children were from the rural population (55.26%), and the mean body mass index was 14.07. 35 children presented with DKA (92.11%), with the majority of severe type (51.43%). Mean random blood sugar was 601.75, and mean hemoglobin A1c (HbA1C) was 11.70. Mean HbA1C in males versus females was 11.48 vs. 10.44, in newly versus previously diagnosed cases was (10.29 vs. 11.94), and in children with normal versus low Vitamin D levels was (10.4 vs. 13.4). Most presenting complaints were polyuria (57.89%), fever (42.10%), and lethargy (39.47%). Other associated significant comorbidities were hypothyroidism (10.52%) and dyslipidemia (15.79%). Only 21.05% were using newer insulin analogs (glargine); 4 children (10.52%) succumbed during treatment.
Conclusion: Steps should be taken to increase awareness regarding the disease among people. The government should also ensure the availability of newer insulin analogs, which are found to be user-friendly at an affordable price.
Downloads
References
1. Magliano DJ, Boyko EJ. IDF Diabetes Atlas. Scientific Committee. 10th ed. Brussels: International Diabetes Federation; 2021.
2. Praveen PA, Madhu SV, Mohan V, Das S, Kakati S, Shah N, et al. Registry of youth onset diabetes in India (YDR): Rationale, recruitment, and current status. J Diabetes Sci Technol. 2016;10(5):1034-41. doi: 10.1177/1932296816645121, PMID 27179010
3. Kumar P, Krishna P, Reddy SC, Gurappa M, Aravind SR, Munichoodappa C. Incidence of type 1 diabetes mellitus and associated complications among children and young adults: Results from Karnataka diabetes registry 1995-2008. J Indian Med Assoc. 2008;106(11):708-11. PMID 19368094
4. Passanisi S, Salzano G, Aloe M, Bombaci B, Citriniti F, De Berardinis F, et al. Increasing trend of type 1 diabetes incidence in the pediatric population of the Calabria region in 2019-2021. Ital J Pediatr. 2022;48(1):66. doi: 10.1186/s13052-022-01264-z, PMID 35509062
5. Karahan E, Alpcan A, Kandur Y, Tursun S, Törel Ergür A, Yörübulut S. Evaluation of children with type 1 diabetes in Kırıkkale. Intercont J Emerg Med. 2023;1(3):37-41. doi: 10.51271/ICJEM-0011
6. Kalra S, Kalra B, Sharma A. Prevalence of type 1 diabetes mellitus in Karnal district, Haryana State, India. Diabetol Metab Syndr. 2010;2:14. doi: 10.1186/1758-5996-2-14, PMID 20214794
7. Verma H, Verma PK, Kumar V, Bhat N, Bahurupi Y. Prevalence and associated clinical features of type 1 diabetes mellitus among children presented to a tertiary health care center of Himalayan foothills. Cureus. 2023;15(2):e35435. doi: 10.7759/cureus.35435, PMID 36994279
8. Pasi R, Ravi KS. Type 1 diabetes mellitus in pediatric age group: A rising endemic. J Fam Med Prim Care. 2022;11(1):27-31. doi: 10.4103/jfmpc.jfmpc_975_21, PMID 35309606
9. Demirbilek H, Özbek MN, Baran RT. Incidence of type 1 diabetes mellitus in Turkish children from the Southeastern region of the country: A regional report. J Clin Res Pediatr Endocrinol. 2013;5(2):98-103. doi: 10.4274/Jcrpe.954, PMID 23748062
10. Hockett CW, Praveen PA, Ong TC, Amutha A, Isom SP, Jensen ET, et al. Clinical profile at diagnosis with youth-onset type 1 and type 2 diabetes in two pediatric diabetes registries: SEARCH (United States) and YDR (India). Pediatr Diabetes. 2021;22(1):22-30. doi: 10.1111/ pedi.12981, PMID 31953884
11. Kao KT, Islam N, Fox DA, Amed S. Incidence trends of diabetic ketoacidosis in children and adolescents with type 1 diabetes in British Columbia, Canada. J Pediatr. 2020;221:165-73.e2. doi: 10.1016/j. jpeds.2020.02.069, PMID 32446476
12. Gesuita R, Maffeis C, Bonfanti R, Cardella F, Citriniti F, D’Annunzio G, et al. Socioeconomic inequalities increase the probability of ketoacidosis at diagnosis of type 1 diabetes: A 2014-2016 nationwide study of 2,679 Italian children. Front Pediatr. 2020;8:575020. doi: 10.3389/fped.2020.575020, PMID 33194905
13. Lokulo-Sodipe K, Moon RJ, Edge JA, Davies JH. Identifying targets to reduce the incidence of diabetic ketoacidosis at diagnosis of type 1 diabetes in the UK. Arch Dis Child. 2014;99(5):438-42. doi: 10.1136/ archdischild-2013-304818, PMID 24395643
14. Suzuki S, Koga M, Amamiya S, Nakao A, Wada K, Okuhara K, et al. Glycated albumin but not HbA1c reflects glycaemic control in patients with neonatal diabetes mellitus. Diabetologia. 2011;54(9):2247-53. doi: 10.1007/s00125-011-2211-8, PMID 21644010
15. Wilkin TJ. The convergence of type 1 and type 2 diabetes in childhood: The accelerator hypothesis. Pediatr Diabetes. 2012;13(4):334-9. doi: 10.1111/j.1399-5448.2011.00831.x, PMID 22059423
16. Wasyl-Nawrot B, Wójcik M, Nazim J, Skupień J, Starzyk JB. Increased incidence of type 1 diabetes in children and no change in the age of diagnosis and BMI-SDS at the onset - is the accelerator hypothesis not working? J Clin Res Pediatr Endocrinol. 2020;12(3):281-6. doi: 10.4274/jcrpe.galenos.2020.2019.0133
17. Varadarajan P, Sangaralingam T, Senniappan S, Jahnavi S, Radha V, Mohan V. Clinical profile and outcome of infantile onset diabetes mellitus in Southern India. Indian Pediatr. 2013;50(8):759-63. doi: 10.1007/s13312-013-0219-5, PMID 23502672
18. Stene LC, Magnus P, Lie RT, Søvik O, Joner G, Norwegian childhood Diabetes Study Group. Birth weight and childhood onset type 1 diabetes: Population based cohort study. BMJ. 2001;322(7291):889-92. doi: 10.1136/bmj.322.7291.889, PMID 11302899
19. Gomase SV, Biswal PK. Clinical profile of type 1 diabetes mellitus in children less than 18 years age, in a tertiary care centre, Bhilai, Chhatisgarh, India: A cross-sectional study. J Clin Diagn Res. 2023;17:SC01-5. doi: 10.7860/JCDR/2023/58298.18114
20. Peng W, Yuan J, Chiavaroli V, Dong G, Huang K, Wu W, et al. 10-year incidence of diabetic ketoacidosis at type 1 diabetes diagnosis in children aged less than 16 years from a large regional center (Hangzhou, China). Front Endocrinol (Lausanne). 2021;12:653519. doi: 10.3389/ fendo.2021.653519, PMID 33986725
21. Shaltout AA, Channanath AM, Thanaraj TA, Omar D, Abdulrasoul M, Zanaty N, et al. Ketoacidosis at first presentation of type 1 diabetes mellitus among children: A study from Kuwait. Sci Rep. 2016;6:27519. doi: 10.1038/srep27519, PMID 27328757
22. Grönberg A, Espes D, Carlsson PO. Better HbA1c during the first years after diagnosis of type 1 diabetes is associated with residual C peptide 10 years later. BMJ Open Diabetes Res Care. 2020;8(1):e000819. doi: 10.1136/bmjdrc-2019-000819, PMID 32107263
23. Mianowska B, Fendler W, Szadkowska A, Baranowska A, Grzelak-Agaciak E, Sadon J, et al. HbA(1c) levels in schoolchildren with type 1 diabetes are seasonally variable and dependent on weatherconditions. Diabetologia. 2011;54(4):749-56. doi: 10.1007/s00125- 010-2013-4, PMID 21188352
24. Ahuja S, Sugandha S, Kumar R, Zaheer S, Singh M. Seasonal variation of HbA1c levels in diabetic and non-diabetic patients. Pract Lab Med. 2024;40:e00396. doi: 10.1016/j.plabm.2024.e00396, PMID 38711868
25. Frommer L, Kahaly GJ. Type 1 diabetes and associated autoimmune diseases. World J Diabetes. 2020;11(11):527-39. doi: 10.4239/wjd.v11. i11.527, PMID 33269064
26. Popoviciu MS, Kaka N, Sethi Y, Patel N, Chopra H, Cavalu S. Type 1 diabetes mellitus and autoimmune diseases: A critical review of the association and the application of personalized medicine. J Pers Med. 2023;13(3):422. doi: 10.3390/jpm13030422, PMID 36983604
27. Molho-Pessach V, Lerer I, Abeliovich D, Agha Z, Abu Libdeh A, Broshtilova V, Elpeleg O, Zlotogorski A. The H syndrome is caused by mutations in the nucleoside transporter hENT3. Am J Hum Genet. 2008;83(4):529-34. doi: 10.1016/j.ajhg.2008.09.013. PMID: 18940313.
28. Dankers W, Colin EM, Van Hamburg JP, Lubberts E. Vitamin D in autoimmunity: Molecular mechanisms and therapeutic potential. Front Immunol. 2016;7:697. doi: 10.3389/fimmu.2016.00697, PMID 28163705
29. Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: A birth-cohort study. Lancet. 2001;358(9292):1500-3. doi: 10.1016/S0140-6736(01)06580-1, PMID 11705562
30. Borkar VV, Devidayal, Verma S, Bhalla AK. Low levels of vitamin D in north Indian children with newly diagnosed type 1 diabetes. Pediatr Diabetes. 2010;11(5):345-50. doi: 10.1111/j.1399-5448.2009.00589.x, PMID 19906128
31. Steck AK, Rewers MJ. Genetics of type 1 diabetes. Clin Chem. 2011;57(2):176-85. doi: 10.1373/clinchem.2010.148221, PMID 21205883
32. Selvaraj M, Prasad HK, White S, Prasanna B, Sangaralingam T. Prevalence and determinants of occurrence of dyslipidemia in subjects with type 1 diabetes mellitus. Indian J Pediatr. 2023;90(2):118-23. doi: 10.1007/s12098-022-04130-2, PMID 35366198
33. Poovazhagi V. Risk factors for mortality in children with diabetic keto acidosis from developing countries. World J Diabetes. 2014;5(6):932-8. doi: 10.4239/wjd.v5.i6.932, PMID 25512799
34. Donepudi A, Donepudi HS, Ayyagari M. Insulin usage and practices in children and adolescents with type 1 diabetes. Indian J Endocrinol Metab. 2021;25(1):38-42. doi: 10.4103/ijem.IJEM_92_21, PMID 34386392
35. Hartman I. Insulin analogs: Impact on treatment success, satisfaction, quality of life, and adherence. Clin Med Res. 2008;6(2):54-67. doi: 10.3121/cmr.2008.793, PMID 18801953
36. Grunberger G. Insulin analogs-are they worth it? yes! Diabetes Care. 2014;37(6):1767-70. doi: 10.2337/dc14-0031, PMID 24855159
37. Jangir R, Sengar GS, Dwivedi T, Aswani N. Neurological abnormalities in children with type 1 diabetes mellitus. Asian J Pharm Clin Res. 2023 Sep 7;16(9):16-9. doi: 10.22159/ajpcr.2023v16i9.47850
38. Chua BW, Lim XY, Poh KM, Caleb JS, Cheen MH, Lim ST, et al. Adherence to insulin in Singaporean pediatric type 1 diabetes patients and its impact on glycemic control and health-care utilization. Asian J Pharm Clin Res. 2019 Dec 7;12(12):176-82.
Published
How to Cite
Issue
Section
Copyright (c) 2025 VENKATA VIJAYALAKSHMI, Dr Jhansi Padma K, Dr N Madhavi, Dr D Manikyamba

This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.